SomaGenics presents at the NIH Innovation Conference and the Life Science Summit Company Showcase

October 4, 2021 — SomaGenics presented its novel wound healing therapeutic based on the sshRNA RNAi technology to the NIH Innovation Conference. SomaGenics also presented to investors at the Life Sciences Summit, held November 9-10, 2021. 

As a result of its NIH SBIR funding for the wound healing program, SomaGenics was subsidized by the NIH SEED program to present free of charge to these life sciences investor conferences and, with other such participants, received valuable coaching and feedback from the venture capital investment community.